Physician

Marc Toeteberg-Harms, MD

According to 2025 Medicare claims, Marc Toeteberg-Harms, MD (NPI: 1164187019) practices ophthalmology in the Iowa City, IA market, with the plurality of this provider's patient population coming from Johnson, IA. This provider's primary affiliated billing organization is STATE UNIVERSITY OF IOWA (NPI: 1477554814; TIN: 426004813) and primary practice location at 52242-1009. Toeteberg-Harms is affiliated with the WellStar Clinical Partners Medicare ACO, LLC (ACO ID: A4803) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Toeteberg-Harms' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 555 traditional Medicare patients, billed 1,972 HCPCS/CPT codes, and received $105,449 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,140 prescription claims across 477 beneficiaries totaling $154,113 in drug costs, led by Rocklatan (Netarsudil Mesylat/Latanoprost). Open Payments data shows 6 records totaling $368. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$53K$105K2022 Medicare payment: $39,117 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $60,682 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $105,449 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022146537$39,117
2023268894$60,682
20245551,972$105,449

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$77K$154K2022 Drug cost: $31,192 (USD; Tot_Drug_Cst)2023 Drug cost: $106,092 (USD; Tot_Drug_Cst)2024 Drug cost: $154,113 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022117456$31,192
20232531,343$106,092
20244772,140$154,113

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more402502$67
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more165179$45
92083Exam of visual field with extended testing280310$21
92133Imaging of optic nerve324365$15
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's198211$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RocklatanNetarsudil Mesylat/Latanoprost431,784$24,905
LumiganBimatoprost312,044$17,702
Brimonidine TartrateBrimonidine Tartrate40627,159$13,078
CombiganBrimonidine Tartrate/Timolol291,853$12,989
RhopressaNetarsudil Mesylate281,004$10,915

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$368Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Marc Toeteberg-Harms, MD?

Tedicare shows public-source Medicare data for Marc Toeteberg-Harms, MD (NPI 1164187019), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Marc Toeteberg-Harms, MD have ACO affiliation data?

Marc Toeteberg-Harms, MD is shown with ACO affiliation data for WellStar Clinical Partners Medicare ACO, LLC (MSSP, ACO ID A4803) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Marc Toeteberg-Harms, MD?

Marc Toeteberg-Harms, MD is linked to STATE UNIVERSITY OF IOWA (billing NPI 1477554814) in the available physician profile data.

Does Marc Toeteberg-Harms, MD have Open Payments data?

Marc Toeteberg-Harms, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.